HuGE Literature Finder
Records
1
-
4
Pan-cancer prognostic genetic mutations and clinicopathological factors associated with survival outcomes: a systematic review. NPJ precision oncology 2022 4 6 (1): 27. Kaubryte Jurgita, Lai Alvina |
Transcriptomic and Genomic Testing to Guide Individualized Treatment in Chemoresistant Gastric Cancer Case. Biomedicines 2020 3 8 (3): . Moisseev Alexey, Albert Eugene, Lubarsky Dan, Schroeder David, Clark Jeffr |
The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes. Mutagenesis 2019 Jun . Wang Na, Li Yan, Zhou Rong-Miao, Cui Sai-Jin, Cao Shi-Ru, Huang Xi, Huo Xiang-Ran, Shan Bao- |
Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population. Molecular biology reports 2013 Aug 40 (8): 4819-26. Marques Inês, Teixeira Ana L, Ferreira Marta, Assis Joana, Lobo Francisco, Maurício Joaquina, Medeiros R |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: